can i take semaglutide if im not diabetic is a diabetes drug, why no hypoglycemia in non-diabetics? How Long Can You Take
Description
Tirzepatide was FDA-approved in 2022 initially for type 2 diabetes management, and then also for weight loss
The complaints contend the companies knew or should have known of a potential association between GLP-1 receptor agonists and optic nerve ischemia but did not timely update labeling or risk communications
Many patients taking GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) experience digestive side effects including nausea, bloating, and altered bowel habits
The case is Mylan Pharm
[DOI] [PubMed] [Google Scholar] 1036.Rogers M., Gill D., Ahlqvist E., Robinson T., Mariosa D., Johansson M., et al
